MILPITAS, Calif., April 25, 2025 /PRNewswire/ — Zepp Health Corporation (“Zepp Health” or the “Company”) (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it has filed its annual report on Form 20-F for the full year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the “SEC”).

The annual report can be accessed on the Company’s investor relations website at http://ir.zepp.com and on the SEC’s website at www.sec.gov. The Company will provide hardcopies of the annual report, free of charge, to its shareholders and ADS holders upon request. Requests should be submitted to ir@zepp.com.

About Zepp Health Corporation (NYSE: ZEPP)

Zepp Health Corporation (NYSE: ZEPP) is a global smart wearable and health technology leader, empowering users to live their healthiest lives by optimizing their health, fitness, and wellness journeys through its leading consumer brands, Amazfit, Zepp Clarity and Zepp Aura. Powered by its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors and data algorithms, Zepp delivers cloud-based 24/7 actionable insights and guidance to help users attain their wellness goals. To date, Zepp has shipped over 200 million units, and its products are available in more than 90 countries and regions. Founded in 2013 as Huami Corp., the Company changed its name to Zepp Health Corporation in February 2021 to emphasize its health focus with a name that resonates across languages and cultures globally. Zepp has team members and offices across globe, especially in Europe and USA regions.

For investor and media inquiries, please contact:

In China:
Zepp Health Corporation
Grace Yujia Zhang
Email: ir@zepp.com 

Piacente Financial Communications
Tel: +86-10-6508-0677
Email: zepp@tpg-ir.com 

View original content:https://www.prnewswire.com/news-releases/zepp-health-corporation-files-2024-annual-report-on-form-20-f-302438423.html

SOURCE Zepp Health Corp.

MIAMI, April 25, 2025 /PRNewswire/ — Symphony Robotics, a pioneer in advanced neurosurgical micro-robotics, today announced the appointment of renowned neurosurgeon Dr. Neil A. Martin as its Chief Medical Officer (CMO). In this pivotal role, Dr. Martin will lead the advancement of the company’s groundbreaking, engine-free, nonlinear, flexible micro-robotic system, poised to transform the treatment landscape for Glioblastoma Multiforme (GBM).

“Glioblastoma remains the most treatment-resistant and lethal primary brain tumor, with a median survival of only 14-16 months following maximal safe resection plus adjuvant chemoradiotherapy, and a five-year survival rate below 7%,” stated Dr. Martin. “Despite significant advances in molecular characterization and targeted therapeutics, meaningful improvements in clinical outcomes have remained elusive.”

Early preclinical studies using anatomically accurate GBM models under real-time MRI guidance have shown that Symphony Robotics’ platform achieves significant improvements in maneuverability, resulting in up to 3 times the volumetric coverage when compared with existing technologies, with millimeter-level precision, crucial for protecting critical healthy brain tissue while maximizing tumor removal.

Dr. Martin continued, “Symphony Robotics is positioned to transform the treatment paradigm by substantially extending the capabilities of Laser Interstitial Thermal Therapy (LITT) in GBM—potentially tripling the ablation volume achievable through its steerability after single-site minimally invasive insertion. Our initial objective is to significantly enhance the efficacy of LITT through precise, nonlinear navigation to previously unreachable tumor margins, even in large and irregular tumors. We are implementing an aggressive translational research pipeline for developing applications to accompany and synergize with thermal ablation, including targeted drug and immunotherapy delivery systems for precision neuro-oncology.”

“Symphony Robotics is built on a foundation of rigorous research and a robust intellectual property portfolio, supported by grants from the National Institutes of Health (NIH) and the National Science Foundation (NSF), and exclusively licensed from Case Western Reserve University,” said Mordechai (Moty) Avisar, Founder and CEO of Symphony Robotics. “Welcoming Dr. Martin—a visionary leader in neurosurgery—to our team marks a pivotal milestone that will accelerate our mission to revolutionize GBM treatment. By harnessing the power of artificial intelligence, our platform is poised to optimize therapy and deliver this life-changing technology to patients worldwide.”

The company is currently establishing collaborations with leading neurosurgical centers to initiate beta site testing later this year, ensuring thorough clinical assessment in diverse patient populations and anatomical scenarios.

CONTACT: info@symphonyrobotics.health
LinkedIn: https://www.linkedin.com/company/symphonyrobotics/

Symphony Robotics is developing advanced medical technology focused on transforming neurosurgical precision through its engine-free, nonlinear, flexible, micro-robotic platform, leveraging AI to optimize GBM treatment. Recognizing the limitations of current techniques in treating complex intracranial pathologies, particularly aggressive cancers like GBM and medically refractory epilepsy, the company aims to improve surgical outcomes by enabling more precise and extensive tumor ablation, minimizing damage to healthy brain tissue, and ultimately improving both patient survival and quality of life. The integration of real-time MRI guidance with advanced robotics and computational navigation algorithms allows their innovative platform to access and treat previously unreachable areas within the brain. Disclaimer: Symphony Robotics’ products are not approved by the Food and Drug Administration (FDA) and are not available for commercial distribution or clinical use.

View original content to download multimedia:https://www.prnewswire.com/news-releases/symphony-robotics-welcomes-neurosurgery-leader-dr-neil-a-martin-as-chief-medical-officer-to-revolutionize-glioblastoma-treatment-with-first-ever-mri-steerable-micro-robotics-302438762.html

SOURCE Symphony Robotics

DALLAS, April 25, 2025 /PRNewswire/ — Graze Robotics, a leader in autonomous mowing technology, is proud to announce a strategic partnership with Invited (formerly ClubCorp), the largest owner and operator of private golf and country clubs in North America. This collaboration will introduce Graze’s innovative robotic mowing solutions to Gleneagles Country Club in Dallas, TX, as part of a groundbreaking pilot program running through 2025.

This initiative marks a significant step in the evolution of golf course maintenance, leveraging cutting-edge robotics to optimize turf management while enhancing sustainability and operational efficiency. The pilot will focus on demonstrating the capabilities of Graze’s robotic mowers in maintaining the rough and fairways, key areas that demand precision, consistency, and efficiency in high-end golf course operations.

“We are always seeking innovative solutions that enhance the quality and sustainability of our course management practices,” said David Pillsbury, CEO of Invited. “Graze’s technology represents an exciting advancement in how we can maintain pristine playing conditions while reducing our environmental footprint. We look forward to seeing the impact of this partnership at Gleneagles.”

Graze’s autonomous mowers offer numerous benefits, including lower fuel consumption and consistent course conditions—all while contributing to environmental sustainability through electric-powered operation. The pilot at Gleneagles will provide critical insights into how robotic mowing can complement and enhance traditional maintenance practices.

“Our partnership with Invited is a testament to the growing demand for intelligent automation in golf course management,” said Logan Fahey Franz, Chief Executive Officer of Graze Robotics. “Gleneagles provides the perfect environment to showcase the capabilities of our technology, and we’re excited to demonstrate how robotic mowing can help elevate course conditions while optimizing labor and resource efficiency.”

As the pilot progresses, Graze and Invited will collaborate closely to evaluate performance metrics, refine operational strategies, and explore opportunities for broader deployment across Invited’s extensive network of premier golf courses.

For more information about Graze Robotics and its autonomous mowing solutions, visit www.grazerobotics.com.

Media Contact:
Francie Holmes
fholmes@grazerobotics.com
972.598.9753

About Graze Robotics: Graze Robotics is a pioneering company in autonomous mowing solutions, specializing in sustainable and efficient robotic technology for large-scale landscaping and golf course maintenance.

About Invited: Since its founding in 1957, Dallas-based Invited has operated with the mission of Building Relationships and Enriching Lives®. The leading owner-operator of membership golf and country clubs and city clubs in North America, Invited is relentless in its pursuit of providing extraordinary experiences, meaningful connections, shared passions, and memorable moments for approximately 350,000 members. The company’s mission is supported by nearly 20,000 peak-season employees and a portfolio of over 160 owned or operated golf and country clubs and city clubs in 26 states. Invited creates communities that cater to an aspirational lifestyle through its championship golf courses, workspaces, handcrafted cuisine, resort-style pools, tennis and pickleball facilities, golf lounges, fitness centers, and pioneering programming.     

View original content to download multimedia:https://www.prnewswire.com/news-releases/graze-robotics-partners-with-invited-to-launch-autonomous-mowing-pilot-at-gleneagles-country-club-302438785.html

SOURCE Graze Robotics